RxDoctor Payments Data

Carlos Selema, MD

Gastroenterology · Coral Gables, FLNPI 1366483562

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Phathom Pharmaceuticals, Inc. at 58.3% of the total. 2025 is the largest year on record at $287, 4.8 times the $59 reported in 2020. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.

$387in general payments, 2019–2025

Across 12 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$226
  • Braintree Laboratories, Inc.$51
  • Intercept Pharmaceuticals, Inc.$47
  • Redhill Biopharma Inc.$37
  • Madrigal Pharmaceuticals$25
$138,146in research payments, 2019–2025

Across 7 payments — averaging $19,735 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$127K
  • AbbVie$11K

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$387 in reported general payments places this provider in the 15th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024
$12,666
Medicare patients
35
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClenpiqSod Picosulf/Mag Ox/Citric Ac216$37,067
LinzessLinaclotide11$5,665
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates41$2,393
SuprepSodium, Potassium,mag Sulfates22$1,977
Omeprazole286$1,714
Cholestyramine LightCholestyramine24$1,214
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl48$1,061
Doxycycline Monohydrate20$728
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg46$655
CholestyramineCholestyramine (With Sugar)18$653
Dicyclomine Hcl47$618
Hydrocortisone16$473
Esomeprazole Magnesium42$471
Pantoprazole Sodium59$370
Famotidine24$326

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Coral Gables

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →